Jump Financial’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Buy |
238,600
+142,170
| +147% | +$2.05M | 0.04% | 531 |
|
|
2025
Q1 | $665K | Sell |
96,430
-1,912
| -2% | -$13.2K | 0.01% | 963 |
|
|
2024
Q4 | $522K | Buy |
+98,342
| New | +$522K | 0.01% | 1049 |
|
|
2024
Q3 | – | Sell |
-25,499
| Closed | -$69.6K | – | 2203 |
|
|
2024
Q2 | $69.6K | Buy |
+25,499
| New | +$69.6K | ﹤0.01% | 1662 |
|
|
2022
Q3 | – | Sell |
-18,000
| Closed | -$30K | – | 2052 |
|
|
2022
Q2 | $30K | Sell |
18,000
-47,700
| -73% | -$79.5K | ﹤0.01% | 1527 |
|
|
2022
Q1 | $162K | Buy |
65,700
+26,800
| +69% | +$66.1K | 0.01% | 1350 |
|
|
2021
Q4 | $145K | Sell |
38,900
-5,092
| -12% | -$19K | 0.01% | 1168 |
|
|
2021
Q3 | $275K | Buy |
43,992
+4,392
| +11% | +$27.5K | 0.02% | 704 |
|
|
2021
Q2 | $390K | Buy |
39,600
+16,000
| +68% | +$158K | 0.04% | 562 |
|
|
2021
Q1 | $220K | Buy |
+23,600
| New | +$220K | 0.02% | 732 |
|